PRRC1

PRRC1 is a cytosolic accessory factor that operates at multiple steps of the secretory pathway. At ER exit sites it is recruited to the inner COPII coat and limits COPII membrane association, thereby tuning anterograde ER-to-Golgi transport (PMID:34433667). At the trans-Golgi network it acts as an essential cytosolic regulator of AP-4-mediated vesicle biogenesis, functioning independently of clathrin to support AP-4-dependent export (PMID:41032520). Beyond trafficking, loss of PRRC1 in glioblastoma cells impairs proliferation, clonogenic survival, and anchorage-independent growth and elevates γ-H2AX under genotoxic stress, linking PRRC1 to proliferative fitness and the DNA damage response in these cells (PMID:41932066). A t(5;11) chromosomal translocation can fuse PRRC1 in-frame to MLL (KMT2A) in secondary acute lymphoblastic leukemia (PMID:25205603). The molecular basis connecting PRRC1's trafficking functions to its DNA-damage and oncogenic roles has not been characterized in the available corpus.

1. 2014 Medium

   Before any biochemical function was known, characterizing a leukemia breakpoint established that the PRRC1 locus can be rearranged, identifying it as an MLL fusion partner.

   Evidence Banding cytogenetics, FISH, and LDI-PCR breakpoint mapping in a secondary ALL patient case

   PMID:25205603

   Open questions at the time

   • Single patient case; recurrence not established
   • No functional test of the 5'MLL-3'PRRC1 fusion protein
   • Does not address normal PRRC1 cellular function
2. 2021 High

   The first mechanistic assignment placed PRRC1 at ER exit sites as a regulator of COPII, answering what cellular process it participates in.

   Evidence In vitro vesicle formation assay, quantitative MS, co-IP, and siRNA knockdown reading out COPII membrane association

   PMID:34433667

   Open questions at the time

   • Precise binding interface within the inner COPII coat not defined
   • Structural basis for negative regulation of COPII membrane association unresolved
3. 2025 High

   Extending its trafficking role, PRRC1 was shown to be required at a distinct compartment, the TGN, as an accessory factor for AP-4 vesicle biogenesis.

   Evidence In vitro vesicle formation assay in AP4ε-deficient HeLa cells with label-free quantitative MS and genetic epistasis

   PMID:41032520

   Open questions at the time

   • Direct physical contact between PRRC1 and AP-4 not structurally defined
   • Whether the COPII and AP-4 roles share a common biochemical activity is unknown
4. 2025 Low

   A Golgi colocalization observation tentatively extended PRRC1 into cargo glycosylation, raising whether it influences MUC5AC processing.

   Evidence Co-localization/interaction assay in LUAD cells within a study focused on ST6GalNAc-I

   PMID:40371640

   Open questions at the time

   • Single co-localization observation without functional validation
   • No reciprocal or biochemical confirmation of the interaction
   • Role in MUC5AC glycosylation is inferred, not demonstrated
5. 2026 Medium

   Loss-of-function studies connected PRRC1 to cancer cell fitness and stress adaptation, beyond its trafficking roles.

   Evidence shRNA knockdown in U87 and patient-derived GBM cells with clonogenic, anchorage-independent growth, spheroid, and γ-H2AX assays under genotoxic stress

   PMID:41932066

   Open questions at the time

   • No direct biochemical mechanism linking PRRC1 to the DNA damage response
   • Single-lab finding without orthogonal genetic validation
   • Whether the DDR phenotype is secondary to trafficking defects is unknown

• It remains unknown what unifying molecular activity allows PRRC1 to act at both COPII and AP-4 vesicle steps and whether this relates to its proliferative and DNA-damage roles in cancer.
• No defined catalytic or adaptor activity established
• No structural model of PRRC1 or its interaction interfaces
• Mechanistic link between trafficking function and DDR/oncogenic phenotypes absent